Clinical Trial Update: Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Triacetyluridine plus Fluorouracil versus Gemcitabine in unresectable locally advanced or metastatic pancreatic cancer has been comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Gemzar (gemcitabine)
• Triacetyluridine (Triacetyluridine)

Snippet

Sponsor: Wellstat Therapeutics | Conditions: Drug/Agent Toxicity by Tissue/Organ, Pancreatic Cancer | Phase 3 | Status: COMPLETED